| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2862863 | American Journal of Hypertension | 2006 | 5 Pages |
Abstract
The extent of acute and chronic effects of sildenafil on erectile function and pulse wave profiles is determined by metabolic cardiovascular risk factors. Improved cardiovascular risk factor control is likely to increase the efficacy of phosphodiesterase-5 inhibitor therapy in the treatment of erectile dysfunction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Hemant Solomon, Anthony S. Wierzbicki, Peter J. Lumb, Michelle Lambert-Hammill, Graham Jackson,